Company Filing History:
Years Active: 2014-2015
Title: Innovations by Stephanie Murphy in Alzheimer's Disease Treatment
Introduction
Stephanie Murphy is an accomplished inventor based in West Lebanon, NH (US). She has made significant contributions to the field of Alzheimer's disease treatment, holding 2 patents that focus on innovative methods for addressing cognitive decline associated with amyloid pathology.
Latest Patents
Her latest patents include a method for selectively inhibiting ACAT1 in the treatment of Alzheimer's disease. This invention features methods for stimulating the clearance of amyloid beta in microglia, which helps decrease cognitive decline associated with amyloid pathology. It specifically targets the expression or activity of Acyl-CoA:Cholesterol Acyltransferase 1, while sparing Acyl-CoA:Cholesterol Acyltransferase 2. Another notable patent is also focused on selectively inhibiting the activity of ACAT1, which aims to decrease the size and density of amyloid plaques, further contributing to the treatment of Alzheimer's disease.
Career Highlights
Stephanie Murphy is affiliated with Dartmouth College, where she continues her research and development in the field of Alzheimer's treatment. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Some of her notable coworkers include Ta-Yuan Chang and Catherine C Y Chang, who collaborate with her on various research initiatives.
Conclusion
Stephanie Murphy's innovative patents and dedication to Alzheimer's research highlight her significant role in the scientific community. Her contributions are paving the way for new treatment methods that could greatly benefit those affected by this challenging disease.